Skip to main content
David Hermel, MD, Hematology, La Jolla, CA

DavidJacobHermelMD

Hematology La Jolla, CA

Hematologic Oncology

Physician, Division of Hematology & Oncology, Scripps Clinic

Dr. Hermel is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Hermel's full profile

Already have an account?

  • Office

    10710 N Torrey Pines Rd
    La Jolla, CA 92037
    Phone+1 858-554-8788
    Fax+1 858-554-8946

Summary

  • Dr. David Hermel is currently a hematologist at Scripps Clinic in La Jolla, CA. He completed his fellowship in hematology and oncology at Scripps Clinic and his residency training in internal medicine at the University of Southern California. He received his medical degree from the University of Vermont College of Medicine and completed undergraduate studies at the University of California, Los Angeles.

Education & Training

  • University of Southern California/Los Angeles General Medical Center (USC/LA General)
    University of Southern California/Los Angeles General Medical Center (USC/LA General)Residency, Internal Medicine, 2016 - 2019
  • University of Vermont College of Medicine
    University of Vermont College of MedicineClass of 2016

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2017 - 2025
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Hematology
  • American Board of Internal Medicine Medical Oncology

Publications & Presentations

PubMed

Journal Articles

  • Progress in gastrointestinal cancer immunotherapy  
    David J. Hermel, Melody H. Hermel, Darren S. Sigal, Translational Cancer Research, 2/2017
  • “Check”-ing the Data: A Review of Immune Checkpoint Inhibitor Biomarkers  
    Hermel D, Sigal D, Personalized Medicine in Oncology, 8/1/2016

Books/Book Chapters

Abstracts/Posters

  • Expanded Panel Testing in Patients with Breast or Ovarian Cancer in a Rural Familial Cancer Program
    Hermel D.J., McKinnon W.C., Colello L., Greenblatt M.S., Wood M.E, Cancer Research
  • Tacrolimus Is Effective Immunosuppressive Therapy in Aplastic Anemia
    Chiu V., Hermel D.J., Weitz I.C, Blood
  • PD-1 Inhibition in Cutaneous Squamous Cell Carcinoma
    Hermel D.J., Ragab O., Higgins S., Wysong A., In G.K, ASCO
  • Join now to see all

Press Mentions

  • Reducing Hospital Length of Stay for AML Patients on High-Dose Cytarabine
    Reducing Hospital Length of Stay for AML Patients on High-Dose CytarabineDecember 16th, 2021